Announced
Completed
BIND THERAPEUTICS INC / PFIZER INC. / Acquisition / Private / £29m
Synopsis
Sale of BIND Therapeutics, a clinical-stage developer of Accurins, highly selective targeted and programmable biopharmaceutical therapeutics, to Pfizer, via a stalking horse bankruptcy auction.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.